T cells
Dengue-Targeting T Cells Home to Skin
Dengue-Targeting T Cells Home to Skin
Jenny Rood | Mar 11, 2015
Immune cells specific for the virus are present in the skin of infected patients, a study shows.
Thanks for the Memories
Thanks for the Memories
Ruth Williams | Feb 1, 2015
B and T cells may be the memory masters of the immune system, but research reveals that other cells can be primed by pathogens, too.
Week in Review: June 23–27
Week in Review: June 23–27
Tracy Vence | Jun 27, 2014
Tracking chikungunya virus; reconsidering wood decay-based fungal classification; ASC specks spread inflammation; antibiotic tolerance in E. coli; RIKEN review yields corrections
Deploying the Body’s Army
Deploying the Body’s Army
Jamie Green and Charlotte Ariyan | Apr 1, 2014
Using patients’ own immune systems to fight cancer
Facing Rejection
Facing Rejection
Kate Yandell | Jan 17, 2014
Following face transplant, T cells from donor skin appear to be active at sites of rejection, perhaps to protect the tissue from attack by the recipient immune system.
Top 10 Innovations 2013
Top 10 Innovations 2013
The Scientist Staff | Dec 1, 2013
The Scientist’s annual competition uncovered a bonanza of interesting technologies that made their way onto the market and into labs this year.
Time for T cells
Time for T cells
Ruth Williams | Nov 7, 2013
Circadian rhythms control the development of inflammatory T cells, while jet lag sends their production into overdrive.
Opinion: How HIV Became Positive
Opinion: How HIV Became Positive
JJ More | Sep 17, 2013
Immunotherapies, such as the re-engineered T cells that last year saved a 7-year-old girl’s life, continue to show promise as cancer treatments.
Tumor-Targeting T Cells Engineered
Tumor-Targeting T Cells Engineered
Chris Palmer | Aug 11, 2013
Scientists genetically modify T cells derived from pluripotent stem cells to attack lymphatic tumors.
Preliminary Malaria Vaccine Trial a Success
Preliminary Malaria Vaccine Trial a Success
Kate Yandell | Aug 9, 2013
An intravenous vaccine appears to protect adults from malaria infection in a Phase 1 clinical trial.